4.6 Article

Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy

Related references

Note: Only part of the references are listed.
Review Materials Science, Biomaterials

Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery

Nafeesa Khatoon et al.

Summary: Macrophage membrane-coated nanoparticles show promise in enhancing drug delivery and targeting for the treatment of various diseases.

BIOMATERIALS SCIENCE (2022)

Article Pharmacology & Pharmacy

Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation

Weiyi Xia et al.

Summary: This study developed a novel approach using macrophage-derived cell membrane-coated nanoparticles to deliver rapamycin for the treatment of age-related macular degeneration (AMD). By increasing the local concentration of rapamycin, this noninvasive method effectively attenuated angiogenesis in the eye and activated autophagy in the retinal pigment epithelial (RPE) cells.

ACTA PHARMACEUTICA SINICA B (2022)

Article Chemistry, Multidisciplinary

Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy

Wenya He et al.

Summary: In this study, the researchers discovered that the Mcl-1-specific inhibitor A12 synergizes with ABT to induce potent cell apoptosis in GBM. They also developed a biomimetic nanomedicine that can effectively deliver ABT and A12 to the brain, exhibiting good biocompatibility and efficient blood-brain barrier penetration. This nanomedicine effectively suppressed tumor growth and prolonged the survival time of mice with GBM xenografts without inducing adverse effects.

ACS NANO (2022)

Article Oncology

Tumor-Associated Macrophages in Gliomas-Basic Insights and Treatment Opportunities

Johannes K. Andersen et al.

Summary: Glioma is a group of primary brain tumors, among which glioblastoma is the most malignant one. The glioma microenvironment is dominated by tumor-associated macrophages (TAMs), which are immunosuppressive and hinder treatment effectiveness. Shifting TAMs towards a proinflammatory state through new therapeutic strategies is of great therapeutic interest for glioma treatment.

CANCERS (2022)

Review Biotechnology & Applied Microbiology

Engineering precision nanoparticles for drug delivery

Michael J. Mitchell et al.

Summary: The development of nanoparticles has shown promising clinical applications, overcoming the limitations of therapeutic interventions and biological barriers. Precision therapies have enhanced treatment efficacy through personalized interventions. Advancements in nanoparticle design aim to optimize drug delivery, improving efficacy in general applications and enabling tailored designs for precision applications.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Biotechnology & Applied Microbiology

Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery

Wenyan Hao et al.

Summary: The study successfully developed a cell membrane-based chemoimmunotherapy delivery vehicle for anti-glioma therapy through different modes. The nanosuspension could target cancer cells through homotypic-targeting mechanism and induce immune response by mimicking dendritic cell membrane characteristics.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Biotechnology & Applied Microbiology

Macrophage membrane camouflaged reactive oxygen species responsive nanomedicine for efficiently inhibiting the vascular intimal hyperplasia

Boyan Liu et al.

Summary: The study introduces a novel ROS-responsive biomimetic nanoparticle MM@PCM/RAP coated with macrophage membrane, which possesses targeting advantages and immune system evasion capabilities. This nanoparticle effectively enhances the solubility of rapamycin and controls local cargo release under high levels of ROS accumulation.

JOURNAL OF NANOBIOTECHNOLOGY (2021)

Article Neurosciences

TNFα secreted by glioma associated macrophages promotes endothelial activation and resistance against anti-angiogenic therapy

Qingxia Wei et al.

Summary: The study revealed that GBM cells secrete IL-8 and CCL2 to stimulate GAMs to produce TNF alpha, which induces ECs activation. TNF alpha plays a crucial role in GBM therapy, as its high expression predicts a poor response to Bevacizumab.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Article Pharmacology & Pharmacy

Macrophage membrane-mediated targeted drug delivery for treatment of spinal cord injury regardless of the macrophage polarization states

Wei Tang et al.

Summary: The study demonstrated that macrophage membrane-camouflaged liposomes successfully targeted the injured spinal cord and showed significant therapeutic efficacy in SCI treatment. These nanoparticles reduced cellular uptake in immune cells and enhanced binding to damaged endothelial cells, indicating their potential as a novel therapeutic approach for SCI.

ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2021)

Review Chemistry, Multidisciplinary

Biomimetic and cell-based nanocarriers-New strategies for brain tumor targeting

D. Mendanha et al.

Summary: In the last two decades, significant advances in the treatment of the most common and malignant types of brain tumors have not been achieved, primarily due to difficulties in drug delivery to the central nervous system and associated severe side effects. Research on cell-based nanocarriers is exploring the potential for crossing biological barriers and targeting brain tumors with higher selectivity, offering new hope for safe and effective treatments.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Biochemistry & Molecular Biology

A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells

Daniel Mendanha et al.

Summary: This study evaluated three chalcone derivatives and found that one of them exhibited the most potent anticancer effects in GBM cell lines, successfully reducing the invasion and proliferation capacity of tumor cells; furthermore, this compound was encapsulated into liposomes to retain its strong in vitro growth inhibitory effect, making it a promising starting point for new drug treatments for GBM.

MOLECULES (2021)

Review Infectious Diseases

Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety

Maria Teresa Mascellino et al.

Summary: This review discusses the principal vaccines developed against SARS-CoV-2 during the Covid-19 pandemic, evaluating their mechanisms of action, efficacy, safety, and storage temperature. It also delves into dosing issues, vaccination strategies, monoclonal antibodies, and the challenges posed by virus variants. The review highlights the varying efficacy of different vaccines and emphasizes the importance of vaccination strategies based on age groups to achieve herd immunity quickly.

INFECTION AND DRUG RESISTANCE (2021)

Review Biotechnology & Applied Microbiology

Nanoparticles in the clinic: An update post COVID-19 vaccines

Aaron C. Anselmo et al.

Summary: Nanoparticles serve as a crucial technology in treating cancer, imaging tissues, and facilitating vaccination. The recent Emergency Use Authorization of COVID-19 lipid nanoparticle vaccines has highlighted the potential of nanoparticles as delivery vehicles in the forefront of biotechnology.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)

Review Chemistry, Multidisciplinary

Biomimetic camouflage delivery strategies for cancer therapy

Akmal M. Asrorov et al.

Summary: This paper reviews different biomimetic drug delivery strategies for cancer treatment, focusing on the discussion of their advantages and potential applications.

NANOSCALE (2021)

Article Medicine, Research & Experimental

Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications

Yi Wang et al.

Summary: This study aimed to develop an ideal biomimetic nanoparticle for targeted atherosclerosis (AS) therapy. The results showed that the advanced MM/RAPNPs demonstrated good biocompatibility, effectively inhibited the progression of AS, and displayed favorable safety performance in AS mouse models. These biomimetic nanoparticles may be potential drug delivery systems for safe and effective anti-AS applications.

THERANOSTICS (2021)

Review Pharmacology & Pharmacy

Overcoming the Brain Barriers: From Immune Cells to Nanoparticles

Marc Charabati et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Review Oncology

Nano-Therapies for Glioblastoma Treatment

Edouard Alphandery

CANCERS (2020)

Article Nanoscience & Nanotechnology

Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy

Xi Cao et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Article Biotechnology & Applied Microbiology

Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy

Chunai Gong et al.

JOURNAL OF NANOBIOTECHNOLOGY (2020)

Review Chemistry, Multidisciplinary

Cell membrane coated nanocarriers - an efficient biomimetic platform for targeted therapy

Pratigyan Dash et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Review Materials Science, Biomaterials

Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery

Huaiji Wang et al.

BIOMATERIALS SCIENCE (2020)

Review Oncology

The blood-brain barrier and blood-tumour barrier in brain tumours and metastases

Costas D. Arvanitis et al.

NATURE REVIEWS CANCER (2020)

Review Immunology

Macrophages as regulators of tumour immunity and immunotherapy

David G. DeNardo et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Engineering, Biomedical

Natural killer cell membrane infused biomimetic liposomes for targeted tumor therapy

Arunkumar Pitchaimani et al.

BIOMATERIALS (2018)

Review Chemistry, Multidisciplinary

Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment

Lakshmi Pallavi Ganipineni et al.

JOURNAL OF CONTROLLED RELEASE (2018)

Review Clinical Neurology

Current and future strategies for treatment of glioma

Nancy Ann Oberheim Bush et al.

NEUROSURGICAL REVIEW (2017)

Article Medicine, General & Internal

Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma

James R. Perry et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Article Biochemistry & Molecular Biology

MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma

Y-S Liu et al.

ONCOGENE (2017)

Review Oncology

Cancer nanomedicine: a review of recent success in drug delivery

Stephanie Tran et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2017)

Article Nanoscience & Nanotechnology

Macrophage Cell Membrane Camouflaged Au Nanoshells for in Vivo Prolonged Circulation Life and Enhanced Cancer Photothermal Therapy

Mingjun Xuan et al.

ACS APPLIED MATERIALS & INTERFACES (2016)

Review Neurosciences

The role of microglia and macrophages in glioma maintenance and progression

Dolores Hambardzumyan et al.

NATURE NEUROSCIENCE (2016)

Article Multidisciplinary Sciences

Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy

Hong-Jun Li et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Engineering, Biomedical

Macrophage Cell Membrane Camouflaged Mesoporous Silica Nanocapsules for In Vivo Cancer Therapy

Minjun Xuan et al.

ADVANCED HEALTHCARE MATERIALS (2015)

Article Chemistry, Multidisciplinary

Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery

Ronnie H. Fang et al.

NANO LETTERS (2014)

Review Oncology

Emerging insights into barriers to effective brain tumor therapeutics

Graeme E. Woodworth et al.

FRONTIERS IN ONCOLOGY (2014)

Review Chemistry, Multidisciplinary

Doxil® - The first FDA-approved nano-drug: Lessons learned

Yechezkel (Chezy) Barenholz

JOURNAL OF CONTROLLED RELEASE (2012)

Article Multidisciplinary Sciences

Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform

Che-Ming J. Hu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)